Genprex, Inc.(GNPX)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-15 | LONGNECKER BRENT M Director | Sale | -18 | -0.20%9,157 | $1.23 | $22 | View SEC filing | |
| 2023-04-24 | Varner John Rodney Chairman, President and CEO | Purchase | +19,000 | +1.64%1,180,535 | $1.05 | $20,045 | View SEC filing | |
| 2023-04-24 | VACZY CATHERINE M EVP GC Chief Strategy Officer | Purchase | +20,000 | +8.16%265,000 | $1.07 | $21,478 | View SEC filing | |
| 2021-04-07 | LONGNECKER BRENT M Director | Purchase | +15,000 | +100.00%15,000 | $4.15 | $62,250 | View SEC filing | |
| 2019-09-09 | Varner John Rodney Chief Executive Officer | Purchase | +1,800 | +100.00%1,800 | $0.89 | $1,595 | View SEC filing | |
| 2018-08-02 | Pham Julien L President & COO | Purchase | +500 | +100.00%500 | $3.40 | $1,700 | View SEC filing | |
| 2018-04-05 | Varner John Rodney Chief Executive Officer | Purchase | +10,000 | +1.87%544,735 | $5.00 | $50,000 | View SEC filing | |
| 2018-04-05 | ROTH JACK A 10% Owner | Purchase | +40,000 | +3.08%1,338,999 | $5.00 | $200,000 | View SEC filing | |
| 2018-04-05 | Nance Christy M. 10% Owner | Purchase | +50,000 | +1.69%3,006,298 | $5.00 | $250,000 | View SEC filing |
1-9 of 9